- Pandey, Suraj;
- Calvey, George;
- Katz, Andrea M;
- Malla, Tek Narsingh;
- Koua, Faisal HM;
- Martin-Garcia, Jose M;
- Poudyal, Ishwor;
- Yang, Jay-How;
- Vakili, Mohammad;
- Yefanov, Oleksandr;
- Zielinski, Kara A;
- Bajt, Sasa;
- Awel, Salah;
- Doerner, Katarina;
- Frank, Matthias;
- Gelisio, Luca;
- Jernigan, Rebecca;
- Kirkwood, Henry;
- Kloos, Marco;
- Koliyadu, Jayanath;
- Mariani, Valerio;
- Miller, Mitchell D;
- Mills, Grant;
- Nelson, Garrett;
- Olmos, Jose L;
- Sadri, Alireza;
- Sato, Tokushi;
- Tolstikova, Alexandra;
- Xu, Weijun;
- Ourmazd, Abbas;
- Spence, John CH;
- Schwander, Peter;
- Barty, Anton;
- Chapman, Henry N;
- Fromme, Petra;
- Mancuso, Adrian P;
- Phillips, George N;
- Bean, Richard;
- Pollack, Lois;
- Schmidt, Marius
Here, we illustrate what happens inside the catalytic cleft of an enzyme when substrate or ligand binds on single-millisecond timescales. The initial phase of the enzymatic cycle is observed with near-atomic resolution using the most advanced X-ray source currently available: the European XFEL (EuXFEL). The high repetition rate of the EuXFEL combined with our mix-and-inject technology enables the initial phase of ceftriaxone binding to the Mycobacterium tuberculosis β-lactamase to be followed using time-resolved crystallography in real time. It is shown how a diffusion coefficient in enzyme crystals can be derived directly from the X-ray data, enabling the determination of ligand and enzyme-ligand concentrations at any position in the crystal volume as a function of time. In addition, the structure of the irreversible inhibitor sulbactam bound to the enzyme at a 66 ms time delay after mixing is described. This demonstrates that the EuXFEL can be used as an important tool for biomedically relevant research.